Clarity Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-41
Closed -$3.52K 191
2026
Q1
$3.52K Buy
41
+1
+3% +$96 ﹤0.01% 255
2025
Q4
$3.87K Hold
40
﹤0.01% 216
2025
Q3
$3.81K Hold
40
﹤0.01% 212
2025
Q2
$3.46K Buy
40
+1
+3% +$85 ﹤0.01% 219
2025
Q1
$3.53K Hold
39
﹤0.01% 189
2024
Q4
$3.12K Hold
39
﹤0.01% 191
2024
Q3
$3.48K Buy
39
+1
+3% +$84 ﹤0.01% 172
2024
Q2
$3.02K Hold
38
﹤0.01% 170
2024
Q1
$3.31K Hold
38
﹤0.01% 174
2023
Q4
$3.11K Buy
+38
New +$2.9K ﹤0.01% 174

Other funds holding MDT

Clarity Asset Management's MDT Position: Q2 2026 in Review

Clarity Asset Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 41 shares — an estimated $3.52K sold.

Clarity Asset Management first reported a position in MDT in Q4 2023 and held it in 10 quarters. The position peaked at $3.87K in Q4 2025. 675 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Clarity Asset Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Clarity Asset Management sold 41 Medtronic shares in Q2 2026, an estimated $3.52K.
  • Clarity Asset Management first reported a position in Medtronic in Q4 2023 and held it in 10 quarters.
  • Clarity Asset Management's Medtronic position peaked at $3.87K in Q4 2025.
  • 675 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Clarity Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.